References
- Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59: 1143-1153. https://doi.org/10.1136/gut.2009.192757
- Kim SG, Jung HK, Lee HL, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol 2013; 61:3-26. https://doi.org/10.4166/kjg.2013.61.1.3
- Hwang TJ, Kim N, Kim HB, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 2010;44:536-543.
- Kim YS, Kim SJ, Yoon JH, et al. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther 2011;34:1098-1105. https://doi.org/10.1111/j.1365-2036.2011.04843.x
- Gisbert JP, Calvet X, O'Connor A, Megraud F, O'Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol 2010;44:313-325.
Cited by
- Future Trends ofHelicobacter pyloriEradication Therapy in Korea vol.63, pp.3, 2013, https://doi.org/10.4166/kjg.2014.63.3.158
- Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment of Helicobacter pylori Infection: A Pilot Study vol.17, pp.3, 2013, https://doi.org/10.7704/kjhugr.2017.17.3.132